tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (CPHRF)
OTHER OTC:CPHRF
US Market

Cipher Pharmaceuticals (CPHRF) Financial Statements

Compare
20 Followers

Cipher Pharmaceuticals Financial Overview

Cipher Pharmaceuticals's market cap is currently $318.38M. The company's EPS TTM is $0.51; its P/E ratio is 10.05; Cipher Pharmaceuticals is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 51.33M$ 33.36M$ 21.16M$ 20.68M$ 21.94M
Gross Profit$ 33.77M$ 24.10M$ 17.09M$ 16.68M$ 18.26M
Operating Income$ 16.80M$ 7.85M$ 11.53M$ 12.04M$ 11.82M
EBITDA$ 16.80M$ 11.87M$ 11.53M$ 12.04M$ 13.66M
Net Income$ 27.81M$ 11.54M$ 20.38M$ 26.64M$ 7.76M
Balance Sheet
Cash & Short-Term Investments$ 7.48M$ 17.84M$ 39.83M$ 28.84M$ 20.55M
Total Assets$ 156.22M$ 162.51M$ 86.03M$ 73.78M$ 51.65M
Total Debt$ 5.49M$ 40.58M$ 353.00K$ 428.00K$ 516.00K
Net Debt$ -1.98M$ 22.74M$ -39.47M$ -28.41M$ -20.03M
Total Liabilities$ 30.20M$ 60.17M$ 5.51M$ 9.70M$ 12.75M
Stockholders' Equity$ 126.01M$ 102.34M$ 80.52M$ 64.08M$ 38.90M
Cash Flow
Free Cash Flow$ 30.22M$ 19.50M$ 15.98M$ 10.49M$ 13.81M
Operating Cash Flow$ 30.25M$ 19.55M$ 16.00M$ 10.57M$ 13.81M
Investing Cash Flow$ -72.24K$ -80.04M$ -144.00K$ -81.00K$ 0.00
Financing Cash Flow$ -41.18M$ 39.30M$ -5.24M$ -1.91M$ -2.47M
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

Cipher Pharmaceuticals Debt to Assets

Cipher Pharmaceuticals Cash Flow

Cipher Pharmaceuticals Forecast EPS vs Actual EPS